Global Targeted Alpha-particle Therapy Market Research Report 2025(Status and Outlook)

March 2025 | 163 pages | ID: G3E049526C5EEN
Bosson Research

Abstracts

Report Overview

Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.

This report provides a deep insight into the global Targeted Alpha-particle Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Targeted Alpha-particle Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Targeted Alpha-particle Therapy market in any manner.

Global Targeted Alpha-particle Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bayer

Orano Med

Oncoinvent AS

Perspective Therapeutics

Ablaze Pharma

ARTBIO

Fusion Pharmaceuticals(AstraZeneca)

AlphaGen Therapeutics

Market Segmentation (by Type)

Actinium-225

Astatine-211

Lead-212

Bismuth-213

Others

Market Segmentation (by Application)

Immunotherapy

Peritoneal Carcinomas

Bone Metastases

Leukaemia

Melanomas

Solid Tumours

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Targeted Alpha-particle Therapy Market
• Overview of the regional outlook of the Targeted Alpha-particle Therapy Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Targeted Alpha-particle Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Targeted Alpha-particle Therapy
1.2 Key Market Segments
  1.2.1 Targeted Alpha-particle Therapy Segment by Type
  1.2.2 Targeted Alpha-particle Therapy Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 TARGETED ALPHA-PARTICLE THERAPY MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Targeted Alpha-particle Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Targeted Alpha-particle Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 TARGETED ALPHA-PARTICLE THERAPY MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Targeted Alpha-particle Therapy Product Life Cycle
3.3 Global Targeted Alpha-particle Therapy Sales by Manufacturers (2020-2025)
3.4 Global Targeted Alpha-particle Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Targeted Alpha-particle Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Targeted Alpha-particle Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Targeted Alpha-particle Therapy Manufacturing Sites, Area Served, Product Type
3.8 Targeted Alpha-particle Therapy Market Competitive Situation and Trends
  3.8.1 Targeted Alpha-particle Therapy Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Targeted Alpha-particle Therapy Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 TARGETED ALPHA-PARTICLE THERAPY INDUSTRY CHAIN ANALYSIS

4.1 Targeted Alpha-particle Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF TARGETED ALPHA-PARTICLE THERAPY MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Targeted Alpha-particle Therapy Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Targeted Alpha-particle Therapy Market
5.7 ESG Ratings of Leading Companies

6 TARGETED ALPHA-PARTICLE THERAPY MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Targeted Alpha-particle Therapy Sales Market Share by Type (2020-2025)
6.3 Global Targeted Alpha-particle Therapy Market Size Market Share by Type (2020-2025)
6.4 Global Targeted Alpha-particle Therapy Price by Type (2020-2025)

7 TARGETED ALPHA-PARTICLE THERAPY MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Targeted Alpha-particle Therapy Market Sales by Application (2020-2025)
7.3 Global Targeted Alpha-particle Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Targeted Alpha-particle Therapy Sales Growth Rate by Application (2020-2025)

8 TARGETED ALPHA-PARTICLE THERAPY MARKET SALES BY REGION

8.1 Global Targeted Alpha-particle Therapy Sales by Region
  8.1.1 Global Targeted Alpha-particle Therapy Sales by Region
  8.1.2 Global Targeted Alpha-particle Therapy Sales Market Share by Region
8.2 Global Targeted Alpha-particle Therapy Market Size by Region
  8.2.1 Global Targeted Alpha-particle Therapy Market Size by Region
  8.2.2 Global Targeted Alpha-particle Therapy Market Size Market Share by Region
8.3 North America
  8.3.1 North America Targeted Alpha-particle Therapy Sales by Country
  8.3.2 North America Targeted Alpha-particle Therapy Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Targeted Alpha-particle Therapy Sales by Country
  8.4.2 Europe Targeted Alpha-particle Therapy Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Targeted Alpha-particle Therapy Sales by Region
  8.5.2 Asia Pacific Targeted Alpha-particle Therapy Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Targeted Alpha-particle Therapy Sales by Country
  8.6.2 South America Targeted Alpha-particle Therapy Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Targeted Alpha-particle Therapy Sales by Region
  8.7.2 Middle East and Africa Targeted Alpha-particle Therapy Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 TARGETED ALPHA-PARTICLE THERAPY MARKET PRODUCTION BY REGION

9.1 Global Production of Targeted Alpha-particle Therapy by Region(2020-2025)
9.2 Global Targeted Alpha-particle Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Targeted Alpha-particle Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Targeted Alpha-particle Therapy Production
  9.4.1 North America Targeted Alpha-particle Therapy Production Growth Rate (2020-2025)
  9.4.2 North America Targeted Alpha-particle Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Targeted Alpha-particle Therapy Production
  9.5.1 Europe Targeted Alpha-particle Therapy Production Growth Rate (2020-2025)
  9.5.2 Europe Targeted Alpha-particle Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Targeted Alpha-particle Therapy Production (2020-2025)
  9.6.1 Japan Targeted Alpha-particle Therapy Production Growth Rate (2020-2025)
  9.6.2 Japan Targeted Alpha-particle Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Targeted Alpha-particle Therapy Production (2020-2025)
  9.7.1 China Targeted Alpha-particle Therapy Production Growth Rate (2020-2025)
  9.7.2 China Targeted Alpha-particle Therapy Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Bayer
  10.1.1 Bayer Basic Information
  10.1.2 Bayer Targeted Alpha-particle Therapy Product Overview
  10.1.3 Bayer Targeted Alpha-particle Therapy Product Market Performance
  10.1.4 Bayer Business Overview
  10.1.5 Bayer SWOT Analysis
  10.1.6 Bayer Recent Developments
10.2 Orano Med
  10.2.1 Orano Med Basic Information
  10.2.2 Orano Med Targeted Alpha-particle Therapy Product Overview
  10.2.3 Orano Med Targeted Alpha-particle Therapy Product Market Performance
  10.2.4 Orano Med Business Overview
  10.2.5 Orano Med SWOT Analysis
  10.2.6 Orano Med Recent Developments
10.3 Oncoinvent AS
  10.3.1 Oncoinvent AS Basic Information
  10.3.2 Oncoinvent AS Targeted Alpha-particle Therapy Product Overview
  10.3.3 Oncoinvent AS Targeted Alpha-particle Therapy Product Market Performance
  10.3.4 Oncoinvent AS Business Overview
  10.3.5 Oncoinvent AS SWOT Analysis
  10.3.6 Oncoinvent AS Recent Developments
10.4 Perspective Therapeutics
  10.4.1 Perspective Therapeutics Basic Information
  10.4.2 Perspective Therapeutics Targeted Alpha-particle Therapy Product Overview
  10.4.3 Perspective Therapeutics Targeted Alpha-particle Therapy Product Market Performance
  10.4.4 Perspective Therapeutics Business Overview
  10.4.5 Perspective Therapeutics Recent Developments
10.5 Ablaze Pharma
  10.5.1 Ablaze Pharma Basic Information
  10.5.2 Ablaze Pharma Targeted Alpha-particle Therapy Product Overview
  10.5.3 Ablaze Pharma Targeted Alpha-particle Therapy Product Market Performance
  10.5.4 Ablaze Pharma Business Overview
  10.5.5 Ablaze Pharma Recent Developments
10.6 ARTBIO
  10.6.1 ARTBIO Basic Information
  10.6.2 ARTBIO Targeted Alpha-particle Therapy Product Overview
  10.6.3 ARTBIO Targeted Alpha-particle Therapy Product Market Performance
  10.6.4 ARTBIO Business Overview
  10.6.5 ARTBIO Recent Developments
10.7 Fusion Pharmaceuticals(AstraZeneca)
  10.7.1 Fusion Pharmaceuticals(AstraZeneca) Basic Information
  10.7.2 Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product Overview
  10.7.3 Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product Market Performance
  10.7.4 Fusion Pharmaceuticals(AstraZeneca) Business Overview
  10.7.5 Fusion Pharmaceuticals(AstraZeneca) Recent Developments
10.8 AlphaGen Therapeutics
  10.8.1 AlphaGen Therapeutics Basic Information
  10.8.2 AlphaGen Therapeutics Targeted Alpha-particle Therapy Product Overview
  10.8.3 AlphaGen Therapeutics Targeted Alpha-particle Therapy Product Market Performance
  10.8.4 AlphaGen Therapeutics Business Overview
  10.8.5 AlphaGen Therapeutics Recent Developments

11 TARGETED ALPHA-PARTICLE THERAPY MARKET FORECAST BY REGION

11.1 Global Targeted Alpha-particle Therapy Market Size Forecast
11.2 Global Targeted Alpha-particle Therapy Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Targeted Alpha-particle Therapy Market Size Forecast by Country
  11.2.3 Asia Pacific Targeted Alpha-particle Therapy Market Size Forecast by Region
  11.2.4 South America Targeted Alpha-particle Therapy Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Targeted Alpha-particle Therapy by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Targeted Alpha-particle Therapy Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Targeted Alpha-particle Therapy by Type (2026-2033)
  12.1.2 Global Targeted Alpha-particle Therapy Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Targeted Alpha-particle Therapy by Type (2026-2033)
12.2 Global Targeted Alpha-particle Therapy Market Forecast by Application (2026-2033)
  12.2.1 Global Targeted Alpha-particle Therapy Sales (K Units) Forecast by Application
  12.2.2 Global Targeted Alpha-particle Therapy Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Targeted Alpha-particle Therapy Market Size Comparison by Region (M USD)
Table 5. Global Targeted Alpha-particle Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Targeted Alpha-particle Therapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Targeted Alpha-particle Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Targeted Alpha-particle Therapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Alpha-particle Therapy as of 2024)
Table 10. Global Market Targeted Alpha-particle Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Targeted Alpha-particle Therapy Manufacturing Sites and Area Served
Table 12. Manufacturers Targeted Alpha-particle Therapy Product Type
Table 13. Global Targeted Alpha-particle Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Targeted Alpha-particle Therapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Targeted Alpha-particle Therapy Sales by Type (K Units)
Table 25. Global Targeted Alpha-particle Therapy Market Size by Type (M USD)
Table 26. Global Targeted Alpha-particle Therapy Sales (K Units) by Type (2020-2025)
Table 27. Global Targeted Alpha-particle Therapy Sales Market Share by Type (2020-2025)
Table 28. Global Targeted Alpha-particle Therapy Market Size (M USD) by Type (2020-2025)
Table 29. Global Targeted Alpha-particle Therapy Market Size Share by Type (2020-2025)
Table 30. Global Targeted Alpha-particle Therapy Price (USD/Unit) by Type (2020-2025)
Table 31. Global Targeted Alpha-particle Therapy Sales (K Units) by Application
Table 32. Global Targeted Alpha-particle Therapy Market Size by Application
Table 33. Global Targeted Alpha-particle Therapy Sales by Application (2020-2025) & (K Units)
Table 34. Global Targeted Alpha-particle Therapy Sales Market Share by Application (2020-2025)
Table 35. Global Targeted Alpha-particle Therapy Market Size by Application (2020-2025) & (M USD)
Table 36. Global Targeted Alpha-particle Therapy Market Share by Application (2020-2025)
Table 37. Global Targeted Alpha-particle Therapy Sales Growth Rate by Application (2020-2025)
Table 38. Global Targeted Alpha-particle Therapy Sales by Region (2020-2025) & (K Units)
Table 39. Global Targeted Alpha-particle Therapy Sales Market Share by Region (2020-2025)
Table 40. Global Targeted Alpha-particle Therapy Market Size by Region (2020-2025) & (M USD)
Table 41. Global Targeted Alpha-particle Therapy Market Size Market Share by Region (2020-2025)
Table 42. North America Targeted Alpha-particle Therapy Sales by Country (2020-2025) & (K Units)
Table 43. North America Targeted Alpha-particle Therapy Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Targeted Alpha-particle Therapy Sales by Country (2020-2025) & (K Units)
Table 45. Europe Targeted Alpha-particle Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Targeted Alpha-particle Therapy Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Targeted Alpha-particle Therapy Market Size by Region (2020-2025) & (M USD)
Table 48. South America Targeted Alpha-particle Therapy Sales by Country (2020-2025) & (K Units)
Table 49. South America Targeted Alpha-particle Therapy Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Targeted Alpha-particle Therapy Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Targeted Alpha-particle Therapy Market Size by Region (2020-2025) & (M USD)
Table 52. Global Targeted Alpha-particle Therapy Production (K Units) by Region(2020-2025)
Table 53. Global Targeted Alpha-particle Therapy Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Targeted Alpha-particle Therapy Revenue Market Share by Region (2020-2025)
Table 55. Global Targeted Alpha-particle Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Targeted Alpha-particle Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Targeted Alpha-particle Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Targeted Alpha-particle Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Targeted Alpha-particle Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Bayer Basic Information
Table 61. Bayer Targeted Alpha-particle Therapy Product Overview
Table 62. Bayer Targeted Alpha-particle Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Bayer Business Overview
Table 64. Bayer SWOT Analysis
Table 65. Bayer Recent Developments
Table 66. Orano Med Basic Information
Table 67. Orano Med Targeted Alpha-particle Therapy Product Overview
Table 68. Orano Med Targeted Alpha-particle Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Orano Med Business Overview
Table 70. Orano Med SWOT Analysis
Table 71. Orano Med Recent Developments
Table 72. Oncoinvent AS Basic Information
Table 73. Oncoinvent AS Targeted Alpha-particle Therapy Product Overview
Table 74. Oncoinvent AS Targeted Alpha-particle Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Oncoinvent AS Business Overview
Table 76. Oncoinvent AS SWOT Analysis
Table 77. Oncoinvent AS Recent Developments
Table 78. Perspective Therapeutics Basic Information
Table 79. Perspective Therapeutics Targeted Alpha-particle Therapy Product Overview
Table 80. Perspective Therapeutics Targeted Alpha-particle Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Perspective Therapeutics Business Overview
Table 82. Perspective Therapeutics Recent Developments
Table 83. Ablaze Pharma Basic Information
Table 84. Ablaze Pharma Targeted Alpha-particle Therapy Product Overview
Table 85. Ablaze Pharma Targeted Alpha-particle Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Ablaze Pharma Business Overview
Table 87. Ablaze Pharma Recent Developments
Table 88. ARTBIO Basic Information
Table 89. ARTBIO Targeted Alpha-particle Therapy Product Overview
Table 90. ARTBIO Targeted Alpha-particle Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. ARTBIO Business Overview
Table 92. ARTBIO Recent Developments
Table 93. Fusion Pharmaceuticals(AstraZeneca) Basic Information
Table 94. Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product Overview
Table 95. Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Fusion Pharmaceuticals(AstraZeneca) Business Overview
Table 97. Fusion Pharmaceuticals(AstraZeneca) Recent Developments
Table 98. AlphaGen Therapeutics Basic Information
Table 99. AlphaGen Therapeutics Targeted Alpha-particle Therapy Product Overview
Table 100. AlphaGen Therapeutics Targeted Alpha-particle Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. AlphaGen Therapeutics Business Overview
Table 102. AlphaGen Therapeutics Recent Developments
Table 103. Global Targeted Alpha-particle Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 104. Global Targeted Alpha-particle Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 105. North America Targeted Alpha-particle Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 106. North America Targeted Alpha-particle Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 107. Europe Targeted Alpha-particle Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 108. Europe Targeted Alpha-particle Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 109. Asia Pacific Targeted Alpha-particle Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 110. Asia Pacific Targeted Alpha-particle Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 111. South America Targeted Alpha-particle Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 112. South America Targeted Alpha-particle Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 113. Middle East and Africa Targeted Alpha-particle Therapy Sales Forecast by Country (2026-2033) & (Units)
Table 114. Middle East and Africa Targeted Alpha-particle Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 115. Global Targeted Alpha-particle Therapy Sales Forecast by Type (2026-2033) & (K Units)
Table 116. Global Targeted Alpha-particle Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 117. Global Targeted Alpha-particle Therapy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 118. Global Targeted Alpha-particle Therapy Sales (K Units) Forecast by Application (2026-2033)
Table 119. Global Targeted Alpha-particle Therapy Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Targeted Alpha-particle Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Targeted Alpha-particle Therapy Market Size (M USD), 2024-2033
Figure 5. Global Targeted Alpha-particle Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Targeted Alpha-particle Therapy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Targeted Alpha-particle Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Targeted Alpha-particle Therapy Product Life Cycle
Figure 13. Targeted Alpha-particle Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Targeted Alpha-particle Therapy Revenue Share by Manufacturers in 2024
Figure 15. Targeted Alpha-particle Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Targeted Alpha-particle Therapy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Targeted Alpha-particle Therapy Revenue in 2024
Figure 18. Industry Chain Map of Targeted Alpha-particle Therapy
Figure 19. Global Targeted Alpha-particle Therapy Market PEST Analysis
Figure 20. Global Targeted Alpha-particle Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Targeted Alpha-particle Therapy Market Share by Type
Figure 27. Sales Market Share of Targeted Alpha-particle Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Targeted Alpha-particle Therapy by Type in 2024
Figure 29. Market Size Share of Targeted Alpha-particle Therapy by Type (2020-2025)
Figure 30. Market Size Share of Targeted Alpha-particle Therapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Targeted Alpha-particle Therapy Market Share by Application
Figure 33. Global Targeted Alpha-particle Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Targeted Alpha-particle Therapy Sales Market Share by Application in 2024
Figure 35. Global Targeted Alpha-particle Therapy Market Share by Application (2020-2025)
Figure 36. Global Targeted Alpha-particle Therapy Market Share by Application in 2024
Figure 37. Global Targeted Alpha-particle Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Targeted Alpha-particle Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Targeted Alpha-particle Therapy Market Size Market Share by Region (2020-2025)
Figure 40. North America Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Targeted Alpha-particle Therapy Sales Market Share by Country in 2024
Figure 43. North America Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Targeted Alpha-particle Therapy Market Size Market Share by Country in 2024
Figure 45. U.S. Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Targeted Alpha-particle Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Targeted Alpha-particle Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Targeted Alpha-particle Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Targeted Alpha-particle Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Targeted Alpha-particle Therapy Sales Market Share by Country in 2024
Figure 53. Europe Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Targeted Alpha-particle Therapy Market Size Market Share by Country in 2024
Figure 55. Germany Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Targeted Alpha-particle Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Targeted Alpha-particle Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Targeted Alpha-particle Therapy Market Size Market Share by Region in 2024
Figure 68. China Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Targeted Alpha-particle Therapy Sales and Growth Rate (K Units)
Figure 79. South America Targeted Alpha-particle Therapy Sales Market Share by Country in 2024
Figure 80. South America Targeted Alpha-particle Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Targeted Alpha-particle Therapy Market Size Market Share by Country in 2024
Figure 82. Brazil Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Targeted Alpha-particle Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Targeted Alpha-particle Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Targeted Alpha-particle Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Targeted Alpha-particle Therapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Targeted Alpha-particle Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Targeted Alpha-particle Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Targeted Alpha-particle Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Targeted Alpha-particle Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Targeted Alpha-particle Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Targeted Alpha-particle Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Targeted Alpha-particle Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Targeted Alpha-particle Therapy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Targeted Alpha-particle Therapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Targeted Alpha-particle Therapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Targeted Alpha-particle Therapy Market Share Forecast by Type (2026-2033)
Figure 111. Global Targeted Alpha-particle Therapy Sales Forecast by Application (2026-2033)
Figure 112. Global Targeted Alpha-particle Therapy Market Share Forecast by Application (2026-2033)